71 related articles for article (PubMed ID: 1675853)
1. Structure-activity studies of pyridinylalkyl-isocytosine H1-receptor antihistamines and identification of an active conformation.
Cooper DG; Durant GJ; Ganellin CR; Ife RJ; Meeson ML; Sach GS
Farmaco; 1991 Jan; 46(1):3-19. PubMed ID: 1675853
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacology of two new histamine receptor antagonists related to ranitidine.
Navarro JJ; Almeida JF; Anaya J; Moran JR; Grande M; Caballero MC; Palacios B; Montero MJ; San Roman L
Pharmazie; 1995 Jan; 50(1):12-5. PubMed ID: 7886119
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and activity of pyridine analogues of histamine H2-receptor antagonists.
Agrawal VK; Tang SB; Wolowyk MW; Knaus EE
Drug Des Deliv; 1988 Dec; 3(4):297-307. PubMed ID: 2908227
[TBL] [Abstract][Full Text] [Related]
4. A conformational approach to histamine H2-receptor antagonists.
Bianucci AM; Martinelli A; Da Settimo A
Farmaco Sci; 1984 Aug; 39(8):686-95. PubMed ID: 6148263
[TBL] [Abstract][Full Text] [Related]
5. N(alpha)-imidazolylalkyl and pyridylalkyl derivatives of histaprodifen: synthesis and in vitro evaluation of highly potent histamine H(1)-receptor agonists.
Menghin S; Pertz HH; Kramer K; Seifert R; Schunack W; Elz S
J Med Chem; 2003 Dec; 46(25):5458-70. PubMed ID: 14640554
[TBL] [Abstract][Full Text] [Related]
6. Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
Borella L; Russell J; Rimele TJ; Grimes D; Failli A; Mir GN
Arzneimittelforschung; 1988 Mar; 38(3):366-72. PubMed ID: 2898247
[TBL] [Abstract][Full Text] [Related]
7. Action of stobadine on respiratory and vascular smooth muscle in vivo: evidence for histamine receptor antagonist activity.
Bauer V; Buran L; Babul'ová A
Arch Int Pharmacodyn Ther; 1990; 304():232-46. PubMed ID: 1978643
[TBL] [Abstract][Full Text] [Related]
8. Interactions between histaminergic and cholinergic pathways of gastric motility regulation.
Milenov K; Todorov S; Vassileva M; Zamfirova R; Shahbazian A
Methods Find Exp Clin Pharmacol; 1996; 18(1):33-9. PubMed ID: 8721254
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and H2-antagonist properties of some 1,2,5-thiadiazole-1-oxide derivatives.
Sorba G; Di Stilo A; Gasco AM; Gili M; Gasco A; Orsetti M
Farmaco; 1992 Dec; 47(12):1445-55. PubMed ID: 1363461
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and assessment of formamidines as new histamine H2-receptor antagonists.
Anglada L; Raga M; Márquez M; Sacristán A; Castelló JM; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):431-4. PubMed ID: 9205738
[TBL] [Abstract][Full Text] [Related]
11. Animal pharmacology of the selective histamine H1-receptor antagonist tazifylline.
Poizot A; Dumez D; Ferrandon P; Lefournier C; Michel A; Armstrong JM
Arzneimittelforschung; 1986 Apr; 36(4):695-702. PubMed ID: 2424463
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological comparison of ORF 17910, a potent, long-acting histamine H2-receptor antagonist, to cimetidine and ranitidine.
Katz LB; Scott CK; Shriver DA
J Pharmacol Exp Ther; 1986 Aug; 238(2):587-93. PubMed ID: 2874214
[TBL] [Abstract][Full Text] [Related]
13. [C-2 basically substituted thiazoles with H2-antagonistic action. 21. H2-antihistaminics].
Trumm KA; Sattler HJ; Postius S; Szelenyi I; Schunack W
Arzneimittelforschung; 1985; 35(3):573-7. PubMed ID: 2859863
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of the new H1-receptor antagonist setastine hydrochloride.
Porszász J; Varga F; Porszász KG; Szolscányi J; Barthó L; Petöcz L; Kápolnai L
Arzneimittelforschung; 1990 Dec; 40(12):1340-5. PubMed ID: 1982751
[TBL] [Abstract][Full Text] [Related]
15. Molecular properties of the histamine H2-receptor. Covalent inhibition by tetraamine disulfides.
Chiarini A; Minarini A; Budriesi R; Melchiorre C
Farmaco; 1990 Sep; 45(9):1001-11. PubMed ID: 1980817
[TBL] [Abstract][Full Text] [Related]
16. [Impromidine-analogous guanidines: synthesis and activity at the histamine H2-receptor. 29. Histamine analogs].
Elz S; Schunack W
Arzneimittelforschung; 1988 Mar; 38(3):327-32. PubMed ID: 2898245
[TBL] [Abstract][Full Text] [Related]
17. Piperidine-containing histamine H3 receptor antagonists of the carbamate series: the influence of the additional ether functionality.
Łazewska D; Kieć-Kononowicz K; Pertz HH; Elz S; Stark H; Schunack W
Pharmazie; 2002 Dec; 57(12):791-5. PubMed ID: 12561236
[TBL] [Abstract][Full Text] [Related]
18. Evidence for histamine H1 and H2 receptors in guinea-pig oxyntic cells.
Vinik AI; Heldsinger AA; Skoglund ML
J Pharmacol Exp Ther; 1983 Oct; 227(1):115-21. PubMed ID: 6137553
[TBL] [Abstract][Full Text] [Related]
19. Role of endothelium and nitric oxide in histamine-induced responses in human cranial arteries and detection of mRNA encoding H1- and H2-receptors by RT-PCR.
Jansen-Olesen I; Ottosson A; Cantera L; Strunk S; Lassen LH; Olesen J; Mortensen A; Engel U; Edvinsson L
Br J Pharmacol; 1997 May; 121(1):41-8. PubMed ID: 9146885
[TBL] [Abstract][Full Text] [Related]
20. Anti-Helicobacter pylori agents. 3. 2-[(Arylalkyl)guanidino]-4-furylthiazoles.
Katsura Y; Nishino S; Ohno M; Sakane K; Matsumoto Y; Morinaga C; Ishikawa H; Takasugi H
J Med Chem; 1999 Jul; 42(15):2920-6. PubMed ID: 10425101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
